The One in Your Kitchen Drawer
It’s not a hormone. It’s the pain reliever you’ve been taking for your knee.
Anti-inflammatory painkillers — NSAIDs — carry a cardiovascular risk that is larger and better documented than most of the prescription drugs people panic about. Ibuprofen, naproxen, diclofenac, celecoxib. Most of them sit on a supermarket shelf.
First, an important distinction the headlines blur. Estrogen causes venous clots — the kind that form in a leg vein and can travel to the lungs. NSAIDs mostly don’t do that. They drive arterial events: heart attack and stroke, caused by a clot forming in an artery already narrowed by plaque. Different plumbing, different symptoms, different people at risk. Lumping them together as “blood clots” is how these lists mislead.
The evidence here isn’t thin. The largest analysis of the trial data — pooling hundreds of thousands of patient-years — found that high-dose NSAID use raised major vascular events by roughly a third. And the risk isn’t evenly spread across the drug class, which is the actionable part.
Diclofenac is the outlier. Its cardiovascular risk profile is comparable to rofecoxib — the drug marketed as Vioxx, which was pulled from the market in 2004 over exactly this concern. Diclofenac was not withdrawn. In many countries it’s still sold over the counter.
ADVERTISEMENT
Naproxen is the safest of the traditional NSAIDs on cardiovascular risk. Not risk-free, but consistently the lowest, which is why it tends to be the recommendation for people who need an anti-inflammatory and have heart disease.
Ibuprofen sits in between, and it’s dose-dependent — occasional 200mg tablets for a headache are a different proposition from 2400mg a day for months.
Three more things worth knowing, because they don’t get said:
The risk starts early. The FDA strengthened its warning in 2015 specifically to note that cardiovascular risk can appear within the first weeks of use. This isn’t only a decades-of-use problem.
NSAIDs fight your blood pressure medication. They cause fluid retention and raise blood pressure directly, which blunts whatever your antihypertensive is doing. If you take amlodipine, lisinopril, or a diuretic and your numbers have crept up, the ibuprofen you take for your back is a genuine suspect. Worse, an NSAID combined with an ACE inhibitor and a diuretic is a recognized recipe for acute kidney injury — clinicians call it the triple whammy.
And here’s the switch: for joint pain in a specific place — a knee, a hand, a shoulder — topical NSAID gel works through the skin with minimal absorption into the bloodstream. You get the anti-inflammatory effect where the pain is, and your heart never meets the drug. Diclofenac gel is available without a prescription. For an older adult with arthritis and cardiovascular risk, that swap is one of the better trades in medicine, and hardly anyone is told about it.
